US exempts select Indian specialty drugs from 100% tariff
In short
The United States said some speciality drugs and ingredients from India and 19 other countries will not face a 100% tariff.
The exempted items include drugs for rare diseases and infertility, plus their ingredients. The full list is not stated in the available reporting.
What the reporting says
The United States exempted certain speciality drugs and ingredients imported from India and 19 other countries from a 100% tariff, according to syndicated reporting. The exemption covers drugs for rare diseases and infertility, along with their components, after President Donald Trump’s proclamation on patented pharmaceuticals. The immediate consequence is tariff relief for those imports, but the exact scope of the exemption is not fully detailed in the available reporting.
Why it matters
The reporting says the US carved out a tariff exemption for certain speciality drugs and ingredients from India and 19 other countries. It follows a proclamation imposing a 100% tariff on specified patented pharmaceuticals. The immediate effect is lower trade cost pressure for covered exporters and importers, but the exact product list is not fully stated.